Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT02323620
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT02323620
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Unknown status
Technical summary
Registry record NCT02323620. Randomized; no masking; primary purpose treatment. Start 2019-03 (anticipated); primary completion 2022-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI
- Acronym
- RACE-STEMI
- Condition
- Heart Failure
- Condition
- Myocardial Infarction
- Intervention (Procedure)
- Intracoronary infusion of BM-MC
- Lead sponsor
- American Heart of Poland
Record details
- Record id
cardio:ct-nct02323620- Content hash
27455158d8443e3ad1b82e7d072d7f2e3be2063687feab2b535b792f5ee0c9d5